Advertisement

Antibiotic-ressistant Streptococcus pneumoniae: Implications for Management in the 21st Century

  • Cynthia G. Whitney
  • Nina E. Glass
Chapter
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC, volume 2)

Keywords

Streptococcus Pneumoniae Antimicrob Agent Invasive Pneumococcal Disease Pneumococcal Disease Pneumococcal Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Academy of Pediatrics. (2000). Pneumococcal infections. In L. K. Pickering (Ed.), 2000 red book: Report of the Committee on Infectious Diseases (p. 460). Elk Grove Village, IL: Author.Google Scholar
  2. American Thoracic Society. (2001). Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med, 163, 1730–1754.Google Scholar
  3. Amsden, G. W. (1999). Pneumococcal macrolide resistance—myth or reality? J Antimicrob Chemother, 44, 1–6.PubMedCrossRefGoogle Scholar
  4. Araj, G. F, Bey, H. A., Itani, L. Y., & Kanj, S. S. (1999). Drug-resistant Streptococcus pneumoniae in the Lebanon: Implications for presumptive therapy. Int J Antimicrob Agents, 12, 349–354.PubMedGoogle Scholar
  5. Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A., Koornhof, H., Hayden-Smith, S., & Reid, R. (1976). Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians, 89, 184–189.PubMedGoogle Scholar
  6. Austrian, R., & Gold, J. (1964). Pneumococcal bacteremia with especial [sic] reference to bacteremic pneumococcal pneumonia. Ann Intern Med, 60, 759–776.PubMedGoogle Scholar
  7. Barker, J. H., Musher, D. M., Silberman, R., Phan, H. M., & Watson, D. A. (1999). Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol, 37, 4039–4041.PubMedGoogle Scholar
  8. Barrett, N., Reingold, A., Gershman, K., McCombs, K., Harrison, L., Johnson, S., Hibbs, J., Cassidy, M., Cieslak, P., Craig, A., Jorgensen, J., Feikin, D., Whitney, C., & Chuang, I. (2002). Assessment of Antibiotic-Resistant Streptococcus pneumoniae susceptibility testing practices for Streptococcus pneumoniae—United States, February 2000. Morb Mortal Wkly Rep, 51, 392–394.Google Scholar
  9. Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Jr., Musher, D. M, & Fine, M. J. (2000). Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis, 31, 347–382.PubMedCrossRefGoogle Scholar
  10. Bell, J.M., Turnidge, J.D., Jones, R.N., & The Sentry Regional Participants Group. (2002). Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: Report from the SENTRY antimicrobial surveillance program, (1998–1999) including an in vitro evaluation of BMS284756. Int J Antimicrob Agents, 19, 125–132.PubMedGoogle Scholar
  11. Benbachir, M., Benredjeb, S., Boye, C.S., Dosso, M., Belabbes, H., Kamoun, A., Kaire, O., & Elmdaghri, N. (2001). Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother, 45, 627–629.PubMedCrossRefGoogle Scholar
  12. Black, S., Shinefield, H., Fireman, B., Ray, P., Hansen, J.R., Elvin, L., Ensor, K.M., Hackell, J., Siber, G., Malinoski, F., Madore, D., Chang, I., Kolberger, R., Watson, W., & Austrian, R. (2000). Efficacy, safety and immunogenicity of heptavalent conjugate pneumococcal vaccine in children. Northern California Kaiser Permanente Study Center Group. Pediatr Infect Dis J, 19, 187–195.PubMedGoogle Scholar
  13. Breiman, R. F., Keller, D. W., Phelan, M., Sniadack, H., Stephens, D. S., Rimland, D., Farley, M. M., Schuchat, A., & Reingold, A. L. (2000). Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med, 160, 2633–2638.PubMedCrossRefGoogle Scholar
  14. Brenwald, N., Gill, M., & Wise, R. (1998). Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother, 42, 2032–2035.PubMedGoogle Scholar
  15. British Thoracic Society Standards of Care Committee. (2001). BTS guidelines for the management of community-acquired pneumonia in adults. Thorax, 56, iv1–iv64.CrossRefGoogle Scholar
  16. Brown, D. F. J. (1994). Developments in antimicrobial susceptibility testing. Rev Med Microbiol, 5, 65–75.Google Scholar
  17. Brueggemann, A. B., Coffman, S. L., Rhomberg, P., Huynh, H., Almer, L., Nilius, A., Flamm, R., & Doern, G. V (2002). Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994–1995. Antimicrob Agents Chemother, 46, 680–688.PubMedCrossRefGoogle Scholar
  18. Buckingham, S. C., Brown, S. P., & Joaquin, V. H. (1998). Breakthrough bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia. J Pediatr, 132, 174–176.PubMedGoogle Scholar
  19. Butler, J. C., Breiman, R. F., Campbell, J. F., Lipman, H. B., Broome, C. V., & Facklam, R. R. (1993). Polysaccharide pneumococcal vaccine efficacy: An evaluation of current recommendations. JAMA, 270, 1826–1831.PubMedCrossRefGoogle Scholar
  20. Centers for Disease Control and Prevention. (1997). Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep, 46, 1–24.Google Scholar
  21. Centers for Disease Control and Prevention. (2000). Prevention of pneumococcal disease among infants and young children: Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep, 49(No. RR-9), 1–35.Google Scholar
  22. Charpentier, E., & Tuomanen, E. (2000). Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect, 2, 1855–1864.PubMedCrossRefGoogle Scholar
  23. Chen, D.K., McGeer, A., de Azavedo, J.C., & Low, D.E. (1999). Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med, 341, 233–239.PubMedCrossRefGoogle Scholar
  24. Choi, E., & Lee, H. (1998). Clincial outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis, 26, 1346–1354.PubMedGoogle Scholar
  25. Clavo-Sanchez, A. J., Giron-Gonzalez, J. A., Lopez-Prieto, D., Canueto-Quintero, J., Sanchez-Porto, A., Vergara-Campos, A., Marin-Casanova, P., & Cordoba-Dona, J. A. (1997). Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin Infect Dis, 24, 1052–1059.PubMedGoogle Scholar
  26. Cybulska, J., Jeljaszewicz, J., Lund, E., & Munksgaard, A. (1970). Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy, 15, 304–316.PubMedGoogle Scholar
  27. Dagan, R., Givon-Lavi, N., Zamir, O., Sikuler-Coheh, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002). Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis, 185, 927–936.PubMedCrossRefGoogle Scholar
  28. Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996). Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate vaccine. J Infect Dis, 174, 1271–1278.PubMedGoogle Scholar
  29. Dagan, R., Muallem, M., Melamed, R., Leroy, O., & Yagupsky, P. (1997). Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J, 16, 1060–1064.PubMedGoogle Scholar
  30. Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C, Kibsey, P., Fleming, C., & Low, D. E. (2002). Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med, 346, 747–750.PubMedGoogle Scholar
  31. Deeks, S. L., Palacio, R., Ruinsky, R., et al. (1999). Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics, 103, 409–413.PubMedCrossRefGoogle Scholar
  32. di Fabio, J. L., Castaneda, E., Agudelo, C. I., de la Hoz, F., Hortal, M., Camou, T., Echaniz-Aviles, G., Noemi, M., Barajas, C., Heitmann, L, Hormazabal, J. C., Brandileone, M. C., Dias Vieira, V. S., Regueira, M., Ruvinski, R., Corso, A., Lovgren, M., Talbot, J. A., & de Quadros, C. (2001). Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr Infect Dis J, 20, 959–967.PubMedGoogle Scholar
  33. Doern, G. V. (1995). Interpretive criteria for in vitro antimicrobial susceptibility testing. Rev Med Microbiol, 6, 126–136.Google Scholar
  34. Doern, G. V., Brueggemann, A. B., Pfaller, M. A., & Jones, R. N. (1999). Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: A report from the College of American Pathologists Microbiology Proficiency Survey Program. Arch Path Lab Med, 123, 285–289.PubMedGoogle Scholar
  35. Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000, including a comparison of resistance rates since 1994–1995. Antimicrob Agents Chemother, 45, 1721–1729.PubMedCrossRefGoogle Scholar
  36. Dowell, S. F., Butler, J. C., Giebink, S., Jacobs, M. R., Jernigan, D., Musher, D., Rakowsky, A., Schwartz, B., & Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. (1999a). Acute otitis media: Management and surveillance in an era of pneumococcal resistance—A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J, 18, 1–9.PubMedCrossRefGoogle Scholar
  37. Dowell, S. F., Marcy, S. M., Phillips, W. R., Gerber, M. A., & Schwartz, B. (1998). Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics, 101, 163–165.Google Scholar
  38. Dowell, S. F., Smith, T., Leversedge, K., & Snitzer, J. (1999b). Pneumonia treatment failure associated with highly-resistant pneumococci. Clin Infect Dis, 29, 462–463.PubMedGoogle Scholar
  39. Ekdahl, K., Ahlinder, I., Hansson, H. B., Melander, E., Molstad, S., Soderstrom, M., & Persson, K. (1997). Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis, 25, 1113–1117.PubMedGoogle Scholar
  40. Ertugrul, N., Rodriguez-Barradas, M. C., Musher, D. M., Ryan, M. A. K., Agin, C. S., Murphy, S. J., Shayegani, M., & Watson, D. A. (1997). BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis, 176, 1401–1405.PubMedGoogle Scholar
  41. Evans, W., & Hansman, D. (1963). Tetracycline-resistant pneumococcus. Lancet, i, 451.Google Scholar
  42. Farr, B. M., Johnston, B. L., Cobb, D. K., Fisch, M. J., Germanson, T. P., Adal, K. A., & Anglim, A. M. (1995). Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study. Arch Intern Med, 155, 2336–2340.PubMedCrossRefGoogle Scholar
  43. Fedson, D. S. (1998). Pneumococcal vaccination in the United States and 20 other developed countries. Clin Infect Dis, 26, 1117–1123.PubMedGoogle Scholar
  44. Feikin, D. R., Schuchat, A., Kolczak, M., Barrett, N. L., Harrison, L. H., Lefkowitz, L., McGeer, A., Farley, M. M., Vugia, D. J., Lexau, C., Stefonek, K. R., Patterson, J. E., & Jorgensen, J. H. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health, 90, 223–229.PubMedCrossRefGoogle Scholar
  45. Filipe, S. R., Severina, E., & Tomasz, A. (2002). The murMN operon: A functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae. Proc Natl Acad Sci USA, 99, 1550–1555.PubMedCrossRefGoogle Scholar
  46. Friedland, I. R. (1995). Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J, 14, 885–890.PubMedGoogle Scholar
  47. Friedland, I. R., & Klugman, K. P. (1992). Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child, 146, 920–923.PubMedGoogle Scholar
  48. Frisch, A., Price, A., & Myers, G. (1943). Type VIII pneumococcus: Development of sulfadiazine resistance, transmission by cross infection, and persistence in carriers. Ann Intern Med, 18, 271–278.Google Scholar
  49. Gaillat, J., Zmirou, D., Mallaret, M. R., Rouhan, D., Bru, J. P., Stahl, J. P., Delormas, P., & Micoud, M. (1985). Essai clinique du vaccin antipneumococcique chez des personnes ágées vivant en institution. Rev Epidémiol Santé Publique, 33, 437–444.PubMedGoogle Scholar
  50. Georgopoulos, A., Buxbaum, A., Straschil, U., & Graninger, W. (1998). Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994–96. Scand J Infect Dis, 30, 345–349.PubMedCrossRefGoogle Scholar
  51. Geslin, P., Fremaux, A., Spicq, C., Sissia, G., & Georges, S. (1997). Use of a DNA probe test for identification of Streptococcus pneumoniae nontypable strains. Adv Exp Med Biol, 418, 383–385.PubMedGoogle Scholar
  52. Ghaffar, F., Friedland, I.R., & McCracken, G. H., Jr. (1999). Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Ped Infect Dis J, 18, 638–646.CrossRefGoogle Scholar
  53. Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001). Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods. Ann Intern Med, 134, 479–86.PubMedGoogle Scholar
  54. Gonzales, R., Steiner, J. F., & Sande, M. A. (1997). Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA, 278, 901–904.PubMedCrossRefGoogle Scholar
  55. Gray, B., Converse, 3rd, G., & Dillon, H., Jr. (1980). Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life. J Infect Dis, 142, 923–933.PubMedGoogle Scholar
  56. Grebe, T., Paik, J., & Hakenbeck, R. (1997). A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J Bacterial, 179, 3342–3349.Google Scholar
  57. Gur, D., Guciz, B., Hascelik, G., Esel, D., Sumerkan, B., Over, U., Soyletir, G., Ongen, B., Kaygusuz, A., & Toreci, K. (2001). Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother, 13, 541–545.PubMedGoogle Scholar
  58. Hansman, D., & Bullen, M. (1967). A resistant pneumococcus. Lancet, ii, 264–265.Google Scholar
  59. Hausdorff, W. P., Bryant, J., Paradiso, P. R., & Siber, G. R. (2000). Which pneumococcal serogroups cause the most invasive disease: Implication for conjugate vaccine formulation and use, part 1. Clin Infect Dis, 30, 100–121.PubMedGoogle Scholar
  60. Heffelfinger, J. D., Dowell, S. F., Jorgensen, J. H., Klugman, K. P., Mabry, L. R., Musher, D. M., Plouffe, J. F., Rakowsky, A., Schuchat, A., Whitney, C. G., & Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. (2000). Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med, 160, 1399–1408.PubMedCrossRefGoogle Scholar
  61. Hendley, J. O., Sande, M. A., Stewart, P. M., & Gwaltney, J. M. J. (1975). Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis, 132, 55–61.PubMedGoogle Scholar
  62. Hermans, P. W., Sluijter, M., Elzenaar, K., van Veen, A., Schonkeren, J. J., Nooren, F M., van Leeuwen, W. J., de Neeling, A. J., van Klingeren, B., Verbrugh, H. A., & de Groot, R. (1997). Penicillin-resistant Streptococcus pneumoniae in the Netherlands: Results of a 1-year molecular epidemiologic survey. J Infect Dis, 175, 1413–1422.PubMedCrossRefGoogle Scholar
  63. Ho, P. L., Tse, W. S., Tsang, K. W., Kwok, T. K., Ng, T. K., Cheng, V. C., & Chan, R. M. (2001a). Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study. Clin Infect Dis, 32, 701–707.PubMedCrossRefGoogle Scholar
  64. Ho, P. L., Yam, W. C., Cheung, T. K., Ng, W. W., Que, T. L., Tsang, D. N., Ng, T. K., & Seto, W. H. (2001b). Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerg Infect Dis, 7, 906–908.PubMedCrossRefGoogle Scholar
  65. Ho, P. L., Yung, R. W., Tsang, D. N., Que, T. L., Ho, M., Seto, W. H., Ng, T. K., Yam, W. C., & Ng, W. W. (2001c). Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: Results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother, 48, 659–665.PubMedGoogle Scholar
  66. Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel-Delvallez, M., & Jones, R. N. (2001). Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis, 32, S81–93.CrossRefGoogle Scholar
  67. Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995). The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med, 333, 481–86.PubMedCrossRefGoogle Scholar
  68. Honkanen, P. O., Keistinen, T, Miettinen, L., Herva, E., Sankilampi, U, Laara, E., Leinonen, M., Kivela, S. L., & Makela, P. H. (1999). Incremental effectiveness of pneumococcal vaccine on simultaneously-administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine, 17, 2493–2500.PubMedCrossRefGoogle Scholar
  69. Huebner, R. E., Wasas, A. D., & Klugman, K. P. (2000). Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991–1998. Int J Infect Dis, 4, 214–218.PubMedCrossRefGoogle Scholar
  70. Hyde, T. B., Gay, K., Stephens, D. S., Vugia, D. J., Pass, M., Johnson, S., Barrett, N. L., Schaffner, W., Cieslak, P. R., Maupin, P. S., Zell, E. R., Jorgensen, J. H., Facklam, R. R., Whitney, C. G., & Active Bacterial Core Surveillance/Emerging Infections Program Network. (2001). Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA, 286, 1857–1862.PubMedCrossRefGoogle Scholar
  71. Jacobs, M., Koornhoof, H., Robins-Browne, R., Stevenson, C., Vermaak, Z., Frieman, I., Miller, G., Witcomb, M., Isaacson, M., Ward, J., & Austrian, R. (1978). Emergence of multiply resistant pneumococci. N Engl J Med, 299, 735–740.PubMedCrossRefGoogle Scholar
  72. Kamme, C., Ekdahl, K., & Molstad, S. (1999). Penicillin-resistant pneumococci in southern Sweden, 1993–1997. Microb Drug Res, 5, 31–36.Google Scholar
  73. Kaufman, P. (1947). Pneumonia in old age: Active immunization against pneumonia with pneumococcus polysaccharide: Results of a six year study. Arch Intern Med, 79, 518–531.Google Scholar
  74. Kelley, M., Weber, D., Gilligan, P., & Cohen, M. (2000). Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis, 31, 1008–1011.PubMedCrossRefGoogle Scholar
  75. Kellner, J. D. (2001). Drug-resistant Streptococcus pneumoniae infections: Clinical importance, drug treatment, and prevention. Semin Respir Infect, 16, 186–195.PubMedGoogle Scholar
  76. Kislak, J. (1967). Type 6 pneumococcus resistant to erythromycin and lincomycin. N Engl J Med, 276, 852.PubMedCrossRefGoogle Scholar
  77. Koeth, L. M., Jacobs, M. R., Bajaksouzian, S., Zilles, A., Lin, G., & Appelbaum, P.C. (2002). Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000. Int J Antimicrob Agents, 19, 33–37.PubMedGoogle Scholar
  78. Koivula, I., Stén, M., Leinonen, M., & Mä;kelä;, P. H. (1997). Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial. Am J Med, 103, 281–290.PubMedCrossRefGoogle Scholar
  79. Konradsen, H. B., & Kaltoft, M. S. (2002). Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol, 9, 358–365.PubMedCrossRefGoogle Scholar
  80. Koornhof, H. J., Keddy, K., & McGee, L. (2001). Clonal expansion of bacterial pathogens across the world. J Travel Med, 8, 29–40.PubMedGoogle Scholar
  81. Koskela, M., Leinonen, M., Hä;ivä;, V.-M., Timonen, M., & Mä;kelä;, P. H. (1986). First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis J, 5, 45–50.Google Scholar
  82. Kristiansen, B. E., Sandnes, R. A., Mortensen, L., Tveten, Y., & Vorland, L. (2001). The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low. Clin Microbiol Infect, 7, 682–687.PubMedGoogle Scholar
  83. Kyaw, M. H., Clarke, S., Jones, I. G., & Campbell, H. (2002). Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect, 128, 139–147.PubMedGoogle Scholar
  84. Lagrou, K., Peetermans, W., Verhaegen, J., Lierde, S., Verbist, L., & Eldere, J. (1999). Macrolide resistance in Belgian Streptococcus pneumoniae. J Antimicrob Chemother, 44, 119–121.Google Scholar
  85. Levine, O. S., Farley, M., Harrison, L. H., Lefkowitz, L., McGeer, A., & Schwartz, B. (1999). Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America. Pediatrics, 103, E28.PubMedCrossRefGoogle Scholar
  86. Lipsitch, M. (2001). Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis, 32, 1044–1054.PubMedCrossRefGoogle Scholar
  87. Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., & Hyland, R. H. (2000). Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis, 31, 383–421.PubMedGoogle Scholar
  88. Maraki, S., Christidou, A., & Tselentis, Y. (2001). Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolates from Crete, Greece. Int J Antimicrob Agents, 17, 465–69.PubMedGoogle Scholar
  89. Marchese, A., Mannelli, S., Tonoli, E., Gorlero, F., Toni, M., & Schito, G. C. (2001). Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulatingin Italy: Results of the Italian Epidemiological Observatory Survey (1997–1999). Microb Drug Resist, 7, 277–287.PubMedCrossRefGoogle Scholar
  90. Marchese, A., Tonoli, E., Debbia, E. A., & Schito, G.C. (1999). Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother, 44, 461–464.PubMedCrossRefGoogle Scholar
  91. Marston, B. J., Plouffe, J. F., File, T. M., Jr., Hackman, B. A., Salstrom, S. J., Lipman, H. B., Kolczak, M. S., & Breiman, R. F. (1997). Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med, 157, 1709–1718.PubMedCrossRefGoogle Scholar
  92. Marton, A., & Meszner, Z. (1999). Epidemiological studies on drug resistance in Streptococcus pneumoniae in Hungary: An update for the 1990s. Microb Drug Res, 5, 201–205.Google Scholar
  93. Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999). Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococccal conjugate vaccine. J Infect Dis, 180, 1171–1176.PubMedCrossRefGoogle Scholar
  94. McCaig, L. F., Besser, R. E., & Hughes, J. M. (2002). Trends in antimicrobial prescribing rates for children and adolescents. JAMA, 287, 3096–3102.PubMedCrossRefGoogle Scholar
  95. McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefevre, J. C., Tomasz, A., & Klugman, K. P. (2001). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol, 39, 2565–2571.PubMedCrossRefGoogle Scholar
  96. Melo-Cristino, J., Fernandes, M. L., Serrano, N., & The Portuguese Surveillance Group for the Study of Bacterial Respiratory Pathogens. (2001). A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal. Microb Drug Res, 7, 33–38.CrossRefGoogle Scholar
  97. Mokaddas, E. M., Wilson, S., & Sanyal, S. C. (2001). Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait. J Chemother, 13, 154–160.PubMedGoogle Scholar
  98. Mulholland, K. (1999). Strategies for the control of pneumococcal diseases. Vaccine, 17, S79–S84.PubMedCrossRefGoogle Scholar
  99. National Advisory Committee on Immunization. (2002). Pneumococcal vaccine. In Canadian immunization guide (6th ed., pp. 177–184). Ottawa: Canadian Medical Association.Google Scholar
  100. NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard (5th ed.). In NCCLS document M7-A5 (Vol. 20). Wayne, PA: Author.Google Scholar
  101. NCCLS. (2002). Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement. In NCCLS document M100-S12 (Vol. 22). Wayne, PA: Author.Google Scholar
  102. Normark, B., Novak, R., Örtqvist, Å, Källenius, G., Tuomanen, E., & Normark, S. (2001). Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis, 32, 552–558.PubMedGoogle Scholar
  103. Novak, R., Henriques, B., Charpentier, E., Normark, S., & Tuomanen, E. (1999). Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature, 399, 590–593.PubMedGoogle Scholar
  104. Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., Breiman, R. F., & Active Bacterial Core Surveillance Team. (2000). Cigarette smoking and invasive pneumococcal disease. N Engl J Med, 342, 681–689.PubMedCrossRefGoogle Scholar
  105. Nyquist, A. C., Gonzales, R., Steiner, J. F, & Sande, M. A. (1998). Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA, 279, 875–877.PubMedCrossRefGoogle Scholar
  106. Obaro, S. K., Adegbola, R. A., Banya, W. A. S., & Greenwood, B. M. (1996). Carriage of pneumococci after pneumococcal vaccination. Lancet, 348, 271–272.PubMedCrossRefGoogle Scholar
  107. Obaro, S. K., Adegbola, R. A., Chang, I., Banya, W. A. S., Jaffar, S., McAdam, K. W. J. P., & Greenwood, B. M. (2000). Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J, 19, 463–469.PubMedGoogle Scholar
  108. Örtqvist, Å., Hedlund, J., Burman, L. Å., Elbel, E., Hofer, M., Leinonen, M., Lindblad, I., Sundelof, B., & Kalin, M. (1998). Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-age and elderly people. Lancet, 351, 399–03.PubMedGoogle Scholar
  109. Oteo, J., Alos, J. I., & Gomez-Garces, J. L. (2001). Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: A multicentre surveillance study. J Antimicrob Chemother, 47, 215–218.PubMedCrossRefGoogle Scholar
  110. Overweg, K., Hermans, P. W., Trzcinski, K., Sluijter, M., de Groot, R., & Hryniewicz, W. (1999). Multidrug-resistant Streptococcus pneumoniae in Poland: Identification of emerging clones. J Clin Microbiol, 37, 1739–1745.PubMedGoogle Scholar
  111. Pallares, R., Gudiol, F., Linares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. (1987). Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med, 317, 18–22.PubMedCrossRefGoogle Scholar
  112. Pallares, R., Linares, J., Vadillo, M., et al. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med, 333, 474–480.Google Scholar
  113. Pana, M., Ungureanu, V., Mihalcu, F, Vereanu, A., & Stanescu, C. (1997). Study of resistant pneumococci in Romania between 1973–1995. Adv Exp Med Biol, 418, 471–473.PubMedGoogle Scholar
  114. Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., & Spanish Surveillance Group for Respiratory Pathogens. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998–1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother, 45, 3334–3340.PubMedCrossRefGoogle Scholar
  115. Pneumococcal Molecular Epidemiology Network, 2001. (2002, August 6). http://pneumo.com/physician/html/pmen/history/history.asp
  116. Robinson, K. A., Baughman, W., Rothrock, G., Barrett, N. L., Pass, M., Lexau, C., Damaske, B., Stefonek, K., Barnes, B., Patterson, J., Zell, E. R., Schuchat, A., Whitney, C. G., & Active Bacterial Core Surveillance/Emerging Infections Program Network. (2001). Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era. JAMA, 285, 1729–1735.PubMedGoogle Scholar
  117. Sahm, D. F., Jones, M. E., Hickey, M. L., Diakun, D. R., Mani, S. V., & Thornsberry, C. (2000). Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998. J Antimicrob Chemother, 45, 457–466.PubMedCrossRefGoogle Scholar
  118. Sankilampi, U., Herva, E., Haikala, R., Liimatainen, O., Renkonen, O. V., & Leinonen, M. (1997). Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect, 118, 7–15.PubMedCrossRefGoogle Scholar
  119. Schmitz, F.-J., Verhoef, J., Milatovic, D., & Fluit, A. C. (2001). Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole. Eur J Clin Microbiol Infect Dis, 20, 827–829.PubMedCrossRefGoogle Scholar
  120. Schrag, S. J., Beall, B., & Dowell, S. F. (2000). Limiting the spread of resistant pneumococci: Biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev, 13, 588–601.PubMedCrossRefGoogle Scholar
  121. Schrag, S. J., Pena, C., Fernandez, J., Sanchez, J., Gomez, V, Perez, E., Feris, J. M., & Besser, R. E. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. JAMA, 286, 49–56.PubMedCrossRefGoogle Scholar
  122. Schrag, S. J., Zell, E. R., Schuchat, A., & Whitney, C. G. (2002). Sentinel surveillance: A reliable way to track antibiotic resistance in communities? Emerg Infect Dis, 8, 496–502.PubMedGoogle Scholar
  123. Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997). Bacterial meningitis in the United States in 1995. N Engl J Med, 337, 970–976.PubMedCrossRefGoogle Scholar
  124. Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991). The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med, 325, 1453–1460.PubMedGoogle Scholar
  125. Shayegani, M., Malmberg Parsons, L., Gibbons Jr., W. E., & Campbell, D. (1982). Characterization of nontypable Streptococcus pneumoniae-like organisms from outbreaks of conjunctivitis. J Clin Microbiol, 16, 8–14.PubMedGoogle Scholar
  126. Shibl, A. M., Al Rasheed, A. M., Elbashier, A. M., & Osoba, A. O. (2000). Penicillin-resistant and-intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother, 12, 134–137.PubMedGoogle Scholar
  127. Shinefield, H. R., & Black, S. (2000). Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J, 19, 394–397.PubMedGoogle Scholar
  128. Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., & Shepard, D. S. (1986). Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med, 315, 1318–1327.PubMedCrossRefGoogle Scholar
  129. Sims, R. V, Steinmann, W. C., McConville, J. H., King, L. R., Zwick, W. C., & Schwartz, J. S. (1988). The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med, 108, 653–657.PubMedGoogle Scholar
  130. Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H. J., & Hilleman, M. R. (1977). Protective efficacy of pneumococcal polysaccharide vaccines. JAMA, 238, 2613–2616.PubMedCrossRefGoogle Scholar
  131. Song, J. H., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C. H., Lalitha, M. K., Thomas, K., Perera, J., Yee, T. T., Jamal, E, Warsa, U. C., Vinh, B.X., Jacobs, M.R., Appelbaum, P.C., & Pai, C.H. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asiancountries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis, 28, 1206–1211.PubMedGoogle Scholar
  132. Tait-Kamradt, A., Davies, T., Appelbaum, P., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000). Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother, 44, 3395–3401.PubMedGoogle Scholar
  133. Thornsberry, C., Sahm, D. F., Kelly, L. J., Critchley, I. A., Jones, M. E., Evangelista, A. T., & Karlowsky, J.A. (2002). Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000. Clin Infect Dis, 34, S4–S16.PubMedCrossRefGoogle Scholar
  134. Tillotson, G. S., & Watson, S. J. (2001). Antimicrobial resistance mechanisms: What’s hot and what’s not in respiratory pathogens. Semin Respir Infect, 16, 155–168.PubMedGoogle Scholar
  135. Turett, G. S., Blum, S., Fazal, B. A., Justman, J. E., & Telzak, E. E. (1999). Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis, 29, 321–327.PubMedGoogle Scholar
  136. U.S. Preventive Services Task Force. (1996). Guide to clinical preventive services (2nded.). Baltimore: Williams & Wilkins.Google Scholar
  137. Verhaegen, J., Van De Ven, J., Verbiest, N., Van Eldere, J., & Verbist, L. (2000). Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium—update 1994–98). Clin Microbiol Infect, 6, 308–315.PubMedCrossRefGoogle Scholar
  138. Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., Jorgensen, J. H., & Schuchat, A. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med, 343, 1917–1924.PubMedCrossRefGoogle Scholar
  139. Widdowson, C. A., & Klugman, K. P. (1998). Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis, 4, 277–281.PubMedCrossRefGoogle Scholar
  140. Wortmann, G., & Bennett, S.(1999). Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae. Clin Infect Dis, 29, 1599–1600.PubMedCrossRefGoogle Scholar
  141. Yoshimine, H., Oishi, K., Mubiru, F., Nalwoga, H., Takahashi, H., Amano, H., Ombasi, P., Watanabe, K., Joloba, M., Aisu, T., Ahmed, K., Shimada, M., Mugerwa, R., & Nagatake, T. (2001). Community-acquired pneumonia in Ugandan adults: Short-term parenteral ampicillin therapy for bacterial pneumonia. Am J Trap Med Hyg, 64, 172–177.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Cynthia G. Whitney
  • Nina E. Glass

There are no affiliations available

Personalised recommendations